Da Silva Jorge Santos
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 13SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 33,9362,843,182 held (−1%) | $20.01 | $679K | -45.9% |
| Jul 13SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 68,2892,774,893 held (−2%) | $20.02 | $1.4M | -46.0% |
| Jul 2SEC | MLTXMoonLake Immunotherapeutics | Sell Plan | 47,7752,877,118 held (−2%) | $20.03 | $957K | -46.0% |
| Apr 14SEC | MLTXMoonLake Immunotherapeutics | Sell | 98,1272,976,766 held (−3%) | $18.41 | $1.8M | -41.2% |
| Apr 14SEC | MLTXMoonLake Immunotherapeutics | Sell | 51,8732,924,893 held (−2%) | $18.23 | $946K | -40.6% |
| Dec 10SEC | MLTXMoonLake Immunotherapeutics | Sell | 130,0002,948,577 held (−4%) | $15.08 | $2.0M | -28.2% |
| Dec 10SEC | MLTXMoonLake Immunotherapeutics | Sell | 70,0002,878,577 held (−2%) | $14.49 | $1.0M | -25.3% |
- Sell
CEO Da Silva Jorge Santos sold $679K of MLTX at $20.01 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Da Silva Jorge Santos sold $1.4M of MLTX at $20.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Da Silva Jorge Santos sold $957K of MLTX at $20.03 — pre-scheduled 10b5-1 plan sale.